Remove Data Remove Epilepsy Remove History Remove Pharmaceutical
article thumbnail

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marijuana as a treatment for epilepsy

Cannabis Info

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. WHAT EXACTLY IS EPILEPSY? CONVENTIONAL TREATMENT.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” . School: University of Maryland.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It also has an extensive and diverse history of medicinal use. Data collection.

article thumbnail

What Going Green Means for the Golden State and the Rest of the World

CannaTech

California Hemp History. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. Food and Drug Administration’s approval of a CBD-based drug that treats patients with rare forms of epilepsy by reducing seizures. Industrial hemp field in California (Isoldiol in partnership with Farmtiva).

Hemp 53
article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

The TGA does not evaluate any data relating to the trial. doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed.